Tag: Shockwave Medical
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance...
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outcomes associated with the Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter,...
The Shockwave E8 experience: Featuring the new Shockwave peripheral IVL workhorse
This advertorial is sponsored by Shockwave Medical.
Paul J. Foley III, MD, a vascular surgeon and director of the non-invasive vascular lab at Doylestown Hospital...
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full U.S. launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following...
Shockwave L6 catheter expands treatment options for large-vessel cases
NOTE: This video is ONLY available to watch in selected countries and geographies
The benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy (IVL)...
Shockwave L6 catheter achieves ‘almost pristine’ result in challenging case
NOTE: This video is ONLY available to watch in selected countries and geographies
Experts gathered at the Society for Vascular Surgery’s 2023 Vascular Annual...
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical.
Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the Food and Drug Administration (FDA).
A...
Disrupt PAD III observational study results confirm safety and effectiveness of...
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and...
First patient enrolled in Disrupt BTK II study for long, calcified,...
Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the Shockwave...
VIVA 2021: IVL ‘consistently’ treats real-world calcium in multiple peripheral vessel...
An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL) performs “consistently well” across challenging peripheral vessels, lesions and...
CMS creates new codes for IVL performed below the knee
Shockwave Medical has announced that as part of the calendar year 2021 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule, the Centers for...
Shockwave Medical announces new CMS codes for intravascular lithotripsy
Shockwave Medical has announced new Centers for Medicare & Medicaid Services (CMS) codes for intravascular lithotripsy (IVL), a procedure performed in peripheral arteries in...